Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.44 USD | -1.53% | -2.11% | -17.62% |
13/05 | Mizuho Adjusts Price Target on Insmed to $36 From $35, Keeps Buy Rating | MT |
10/05 | Mizuho Securities Raises Price Target on Insmed to $36 From $35, Keeps Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.62% | 383.85Cr | |
+4.54% | 11TCr | |
+11.14% | 11TCr | |
-12.28% | 2.23TCr | |
-3.76% | 2.19TCr | |
-6.17% | 1.86TCr | |
-35.21% | 1.81TCr | |
-9.38% | 1.7TCr | |
+3.01% | 1.37TCr | |
+36.28% | 1.24TCr |
- Stock Market
- Equities
- INSM Stock
- News Insmed Incorporated
- Transcript : Insmed Incorporated, Q4 2022 Earnings Call, Feb 23, 2023